Intestinal mononuclear phagocytes as prognostic biomarker for crohn's disease
US-2024425923-A1 · Dec 26, 2024 · US
Assays for agents affecting megakaryocyte development
US9017936B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9017936-B2 |
| Application number | US-89859010-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 5, 2010 |
| Priority date | Oct 6, 2009 |
| Publication date | Apr 28, 2015 |
| Grant date | Apr 28, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Methods and kits for identifying candidate anti-megakaryocyte agents are disclosed.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of identifying an anti-megakaryocyte agent comprising: contacting, a cell capable of expressing TRB-3 with an agent to be tested for anti-megakaryocyte activity; measuring expression of TRB-3 in a cell contacted with the test agent; comparing the expression of TRB-3 in a cell contacted with the test agent to a control level of expression; assessing the anti-megakaryocyte activity of a test agent which increases the expression of TRB-3 in a cel…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
- C12Q1/6883Primary
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Physics · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9017936B2 cover?
- Methods and kits for identifying candidate anti-megakaryocyte agents are disclosed.
- Who is the assignee on this patent?
- Erusalimsky Jorge D, Ahluwalia Maninder, Shire Human Genetic Therapies, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification C12Q1/6883. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).